|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_ocn604931464 |
| 003 |
OCoLC |
| 005 |
20231117033041.0 |
| 006 |
m o d |
| 007 |
cr un||||a|a|| |
| 008 |
100407s1984 flu ob 001 0 eng d |
| 040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d OPELS
|d IDEBK
|d E7B
|d OCLCQ
|d OCLCF
|d UIU
|d OCLCQ
|d VLY
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 610478773
|a 1162128225
|
| 020 |
|
|
|a 0323140211
|
| 020 |
|
|
|a 9780323140218
|
| 020 |
|
|
|z 0122808800
|
| 020 |
|
|
|z 9780122808807
|q (alk. paper)
|
| 035 |
|
|
|a (OCoLC)604931464
|z (OCoLC)610478773
|z (OCoLC)1162128225
|
| 042 |
|
|
|a dlr
|
| 050 |
|
4 |
|a QR189.5.B33
|b B33 1984
|
| 060 |
|
4 |
|a WC 200
|b B1316 1984
|
| 082 |
0 |
4 |
|a 615/.372
|2 19
|
| 245 |
0 |
0 |
|a Bacterial vaccines /
|c edited by Ren�e Germanier.
|
| 260 |
|
|
|a Orlando :
|b Academic Press,
|c 1984.
|
| 300 |
|
|
|a 1 online resource (xii, 441 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
| 533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
| 538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
| 583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Front Cover; Bacterial Vaccines; Copyright Page; Table of Contents; Contributors; Preface; Chapter 1. Diphtheria; I. Introduction; II. History of Diphtheria; III. Biology of Diphtheria; IV. Diphtheria Toxin and Toxoid; V. Immunization against Diphtheria; VI. Effect of Mass Immunization on the Epidemiology of Diphtheria; VII. Conclusions and Future Prospects; Acknowledgments; References; Chapter 2. Tetanus; I. Introduction; II. The Causative Agent; III. Pathogenesis; IV. Clinical Features; V. Epidemiology; VI. Presently Available Vaccines; VII. Presentation of Tetanus Vaccines
|
| 505 |
8 |
|
|a VIII. Laboratory Control of Vaccines and WHO RequirementsIX. Clinical Assessment of Vaccines; X. Results of Field Trials Using Conventional and Overdosed Vaccines in One, Two, or Three Injections; XI. Drawbacks; XII. Prospects for New Vaccines; Acknowledgment; References; Chapter 3. Pertussis; I. Introduction; II. Pertussis (Whooping Cough); III. Chemotherapy, Chemoprophylaxis, Pertussis Immune Globulin; IV. Pertussis Vaccine; V. Prospects for New Pertussis Vaccines; VI. Immunization Schedules; VII. Can Pertussis Be Eradicated?; References; Chapter 4. Cholera; I. Prologue; II. Introduction
|
| 505 |
8 |
|
|a III. Conventional Killed Vibrio cholerae Vaccines Administered ParenterallyIV. Killed Vaccines Administered Perorally; V. The Pathogenesis of Cholera; VI. The Cholera Enterotoxin (Choleragen or CT), Its Derivatives, and Its Relatives; VII. Combined Nonliving Vaccines; VIII. Live Vaccines: Ferran and Haffkine Revisited -- Acknowledgment; References; Chapter 5. Typhoid Fever; I. Introduction; II. Presently Available Vaccines; III. Development of New Typhoid Vaccines; IV. Live Oral Vaccines; References; Chapter 6. Shigellosis; I. Introduction; II. Characteristics of Shigellae
|
| 505 |
8 |
|
|a III. Studies of Potential Vaccines in AnimalsIV. Studies of Potential Vaccines in Humans; V. Prospects for New Vaccines; References; Chapter 7. Escherichia coli Infections; I. Introduction; II. Vaccines; References; Chapter 8. Meningococcal Meningitis; I. Introduction; II. Presently Available Vaccines; III. Prospects for New Vaccines; References; Chapter 9. Pneumococcal Infections; I. Pneumococcal Infections; II. Immunity to Pneumococcal Infection; III. Pneumococcal Vaccines; References; Chapter 10. Haemophilus influenzae Type b Infections; I. Introduction; II. Historical
|
| 505 |
8 |
|
|a III. Description of the OrganismIV. Clinical Diseases; V. Vaccine Development; VI. Considerations for Inclusion of Haemophilus influenzae Type b Vaccines for Routine Immunization; VII. Other Vaccine Candidates; References; Chapter 11. Pseudomonas aeruginosa Infections; I. Introduction; II. Epidemiology and Clinical Significance; III. Pathogenesis of Pseudomonas aeruginosa Infections; IV. Currently Developed Vaccines: Clinical Status; V. Human Immunity to Pseudomonas aeruginosa; VI. Future Prospects: Candidate Vaccines and New Therapeutic Regimens; References; Chapter 12. Gonorrhea
|
| 546 |
|
|
|a English.
|
| 650 |
|
0 |
|a Bacterial vaccines.
|
| 650 |
|
2 |
|a Bacterial Infections
|x prevention & control
|0 (DNLM)D001424Q000517
|
| 650 |
|
2 |
|a Bacterial Vaccines
|0 (DNLM)D001428
|
| 650 |
|
6 |
|a Vaccins antibact�eriens.
|0 (CaQQLa)201-0018496
|
| 650 |
|
7 |
|a Bacterial vaccines
|2 fast
|0 (OCoLC)fst00825244
|
| 653 |
|
|
|a Man
|a Bacterial diseases
|a Vaccines
|
| 700 |
1 |
|
|a Germanier, Ren�e.
|
| 776 |
0 |
8 |
|i Print version:
|t Bacterial vaccines.
|d Orlando : Academic Press, 1984
|w (DLC) 84000446
|w (OCoLC)10404316
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780122808807
|z Texto completo
|
